The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
AMBAC FINL GROUP INC COM NEW 023139884 3,047 268,457 SH   SOLE 268,457 0 0
ARBUTUS BIOPHARMA CORP COM 03879J100 9,490 3,501,876 SH   SOLE 3,501,876 0 0
HERTZ GLOBAL HLDGS INC *W EXP 06/30/205 42806J148 402 41,013 SH   SOLE 41,013 0 0
HERTZ GLOBAL HLDGS INC COM NEW 42806J700 34,212 2,159,856 SH   SOLE 2,159,856 0 0
ODYSSEY MARINE EXPL INC COM NEW 676118201 4,193 1,229,579 SH   SOLE 1,229,579 0 0
RENREN INC SPONSORED ADS 759892300 11,500 397,655 SH   SOLE 397,655 0 0
ROIVANT SCIENCES LTD *W EXP 09/30/202 G76279119 67 111,509 SH   SOLE 111,509 0 0
ROIVANT SCIENCES LTD SHS G76279101 13,919 3,419,836 SH   SOLE 3,419,836 0 0